Skip to search formSkip to main contentSkip to account menu

ocriplasmin

Known as: Microplasmin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND/PURPOSE Postmarket analysis helps identify potentially important side effects not discovered during clinical trials… 
Review
2016
Review
2016
BACKGROUND AND OBJECTIVE To study the post-marketing safety profile of ocriplasmin (Jetrea; ThromboGenics, Iselin, NJ) as… 
Review
2015
Review
2015
Purpose: Transient vision loss is a poorly understood complication of ocriplasmin injection. Methods: The authors performed a… 
2015
2015
BACKGROUND AND OBJECTIVE To determine early evolution of the vitreomacular interface and clinical efficacy and safety profile… 
Review
2014
Review
2014
IMPORTANCE Assessing the effect of ocriplasmin availability on the management of full-thickness macular holes (MHs) is important… 
2012
2012
The vitreous may play an important role in the pathogenesis of various retinal disorders. Pharmacologic vitreolysis uses… 
2012
2012
PURPOSE Ocriplasmin contains the active moiety of plasmin enzyme. At a physiologic pH, ocriplasmin is highly proteolytic and… 
Review
2009
Review
2009
Several enzymatic agents, such as autologous plasmin enzyme and recombinant microplasmin, are able to cause vitreous liquefaction…